Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

This bill requires health insurance plans, starting in 2026, to cover intravenous immunoglobulin therapy for children with certain autoimmune neuropsychiatric disorders. Coverage would include an initial three monthly treatments and further treatments if a doctor deems them medically necessary. This coverage is contingent on less intensive treatments failing and a specialist recommending the therapy.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text